Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Alexandra Drakaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8865-3548; OpenAlex author ID A5049657362. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Co-author DOI 10.3390/cimb46040177↗
  2. MicroRNA-gene signaling pathways in pancreatic cancer. First author DOI 10.4103/2319-4170.119690↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximos Frountzas · 1 shared paper, 2024 · strength 0.26
  2. Dimitrios Stefanoudakis · 1 shared paper, 2024 · strength 0.26
  3. Konstantinos G. Toutouzas · 1 shared paper, 2024 · strength 0.26
  4. Dimitriοs Schizas · 1 shared paper, 2024 · strength 0.26
  5. Dimitrios Iliopoulos · 1 shared paper, 2013 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.